Evidence map›Paper›PMID 27015743›Full record

ArticleJournal of lipid research2016

ApoE knockout and knockin mice: the history of their contribution to the understanding of atherogenesis.

Godfrey S Getz, Catherine A Reardon

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 84 citations in OpenAlex.

  1. Step-by-stepMethodsX · 2026
    Article
  2. Review
  3. Selection of appropriate reference genes in ApoeIBRO neuroscience reports · 2026
    Article
  4. Genes · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Walking the VLDL tightrope in cardiometabolic diseases.Trends in endocrinology and metabolism: TEM · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Godfrey S GetzDepartment of Pathology University of Chicago, Chicago, IL getz@bsd.uchicago.edu.
Catherine A ReardonBen May Institute for Cancer Biology, University of Chicago, Chicago, IL.
May Institute · USUniversity of Chicago · US

Funding

Cell Type Specific Roles of ApoE2 in Tissue Inflammation and AtherosclerosisR01HL131028 · NHLBI · UNIVERSITY OF CINCINNATI · PI HUI, DAVID YIU-KWAN, REARDON-ALULIS, CATHERINE A · 2016 to 2019
$2.6M
NHLBI NIH HHS R01 HL131028
6 · The paper itself

Abstract

ApoE is a multifunctional protein that is expressed by many cell types that influences many aspects of cardiovascular physiology. In humans, there are three major allelic variants that differentially influence lipoprotein metabolism and risk for the development of atherosclerosis. Apoe-deficient mice and human apoE isoform knockin mice, as well as hypomorphic Apoe mice, have significantly contributed to our understanding of the role of apoE in lipoprotein metabolism, monocyte/macrophage biology, and atherosclerosis. This brief history of these mouse models will highlight their contribution to the understanding of the role of apoE in these processes. These Apoe(-/-) mice have also been extensively utilized as an atherosensitive platform upon which to assess the impact of modulator genes on the development and regression of atherosclerosis.

Indexed as

AnimalsApolipoproteins EAtherosclerosisCholesterolGene Knock-In TechniquesHumansMacrophagesMiceMice, KnockoutApolipoproteins ECholesterolapolipoprotein Eapolipoproteinscholesterol effluxlipoproteinsmacrophagesmonocytes

Identifiers

PMID27015743
PMCPMC4847636
OpenAlexW2308383021

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.